title	geo_accession	characteristics_ch1	characteristics_ch1.1	characteristics_ch1.2	characteristics_ch1.3	characteristics_ch1.4	characteristics_ch1.5	characteristics_ch1.6	characteristics_ch1.7	characteristics_ch1.8	description	relation	relation.1	% intratumoral tils:ch1	% stromal tils:ch1	clinical stage:ch1	cohort:ch1	event:ch1	expression-based subtype:ch1	morphology:ch1	non-synonymous mutation burden:ch1	time to event:ch1
Patient 264	GSM2735202	expression-based subtype: I	time to event: 30.2	event: Last follow-up	clinical stage: Unknown	% stromal tils: 65	% intratumoral tils: 35	morphology: undifferentiated, round	non-synonymous mutation burden: 256	cohort: Unpaired	NPC0001PT00264T00264	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460349	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070255	35	65	Unknown	Unpaired	Last follow-up	I	undifferentiated, round	256	30.2
Patient 4	GSM2735203	expression-based subtype: II	time to event: 21.1	event: Last follow-up	clinical stage: IV	% stromal tils: Not evaluated	% intratumoral tils: Not evaluated	morphology: N/A	non-synonymous mutation burden: 269	cohort: Unpaired	NPC0001PT00004T00004	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460348	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070256	Not evaluated	Not evaluated	IV	Unpaired	Last follow-up	II	N/A	269	21.1
Patient 78	GSM2735204	expression-based subtype: I	time to event: 21.39	event: Disease progression	clinical stage: III	% stromal tils: 95	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 50	cohort: Paired	NPC0001PT00078T00078	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460347	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070257	5	95	III	Paired	Disease progression	I	mixed (round & spindle)	50	21.39
Patient 234	GSM2735205	expression-based subtype: II	time to event: 23.13333333	event: Last follow-up	clinical stage: Unknown	% stromal tils: 20	% intratumoral tils: 20	morphology: mixed (round & spindle)	non-synonymous mutation burden: 33	cohort: Paired	NPC0001PT00234T00234	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460346	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070258	20	20	Unknown	Paired	Last follow-up	II	mixed (round & spindle)	33	23.13333333
Patient 349	GSM2735206	expression-based subtype: I	time to event: 29.43333333	event: Last follow-up	clinical stage: II	% stromal tils: 80	% intratumoral tils: 2	morphology: differentiated	non-synonymous mutation burden: 287	cohort: Unpaired	NPC0001PT00349T00349	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460345	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070259	2	80	II	Unpaired	Last follow-up	I	differentiated	287	29.43333333
Patient 289	GSM2735207	expression-based subtype: III	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 60	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 24	cohort: Paired	NPC0001PT00289T00289	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460344	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070260	10	60	Unknown	Paired	N/A	III	mixed (round & spindle)	24	N/A
Patient 370	GSM2735208	expression-based subtype: I	time to event: 26.9	event: Last follow-up	clinical stage: IV	% stromal tils: 10	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 31	cohort: Paired	NPC0001PT00370T00370	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460343	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070261	5	10	IV	Paired	Last follow-up	I	mixed (round & spindle)	31	26.9
Patient 29	GSM2735209	expression-based subtype: I	time to event: 39.3	event: Last follow-up	clinical stage: Unknown	% stromal tils: 90	% intratumoral tils: 10	morphology: differentiated	non-synonymous mutation burden: Not evaluated	cohort: N/A	NPC0001PT00029T00029	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460342	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070262	10	90	Unknown	N/A	Last follow-up	I	differentiated	Not evaluated	39.3
Patient 236	GSM2735210	expression-based subtype: I	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 90	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 275	cohort: Unpaired	NPC0001PT00236T00236	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460341	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070263	5	90	Unknown	Unpaired	N/A	I	mixed (round & spindle)	275	N/A
Patient 312	GSM2735211	expression-based subtype: I	time to event: 6.01	event: Disease progression	clinical stage: III	% stromal tils: 10	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 30	cohort: Paired	NPC0001PT00312T00312	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460340	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070264	5	10	III	Paired	Disease progression	I	undifferentiated, round	30	6.01
Patient 61	GSM2735212	expression-based subtype: I	time to event: 40.06666667	event: Last follow-up	clinical stage: IV	% stromal tils: 90	% intratumoral tils: 30	morphology: differentiated	non-synonymous mutation burden: 12	cohort: Paired	NPC0001PT00061T00061	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460339	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070265	30	90	IV	Paired	Last follow-up	I	differentiated	12	40.06666667
Patient 152	GSM2735213	expression-based subtype: III	time to event: 37.9	event: Last follow-up	clinical stage: Unknown	% stromal tils: Not evaluated	% intratumoral tils: Not evaluated	morphology: mixed (round & spindle)	non-synonymous mutation burden: 10	cohort: Paired	NPC0001PT00152T00152	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460338	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070266	Not evaluated	Not evaluated	Unknown	Paired	Last follow-up	III	mixed (round & spindle)	10	37.9
Patient 331	GSM2735214	expression-based subtype: I	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 60	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 282	cohort: Unpaired	NPC0001PT00331T00331	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460337	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070267	5	60	Unknown	Unpaired	N/A	I	undifferentiated, round	282	N/A
Patient 196	GSM2735215	expression-based subtype: III	time to event: 34.5	event: Last follow-up	clinical stage: III	% stromal tils: 90	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 232	cohort: Unpaired	NPC0001PT00196T00196	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460336	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070268	5	90	III	Unpaired	Last follow-up	III	mixed (round & spindle)	232	34.5
Patient 100	GSM2735216	expression-based subtype: I	time to event: 30.96666667	event: Last follow-up	clinical stage: Unknown	% stromal tils: 50	% intratumoral tils: 2	morphology: differentiated	non-synonymous mutation burden: 385	cohort: Paired	NPC0001PT00100T00100	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460335	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070269	2	50	Unknown	Paired	Last follow-up	I	differentiated	385	30.96666667
Patient 437	GSM2735217	expression-based subtype: II	time to event: 22.13333333	event: Last follow-up	clinical stage: IV	% stromal tils: 10	% intratumoral tils: 5	morphology: undifferentiated, spindle	non-synonymous mutation burden: 22	cohort: Paired	NPC0001PT00437T00437	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460334	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070270	5	10	IV	Paired	Last follow-up	II	undifferentiated, spindle	22	22.13333333
Patient 48	GSM2735218	expression-based subtype: I	time to event: 6.34	event: Disease progression	clinical stage: III	% stromal tils: 40	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 17	cohort: Paired	NPC0001PT00048T00048	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460333	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070271	5	40	III	Paired	Disease progression	I	undifferentiated, round	17	6.34
Patient 300	GSM2735219	expression-based subtype: I	time to event: 26.8	event: Last follow-up	clinical stage: III	% stromal tils: 20	% intratumoral tils: 10	morphology: undifferentiated, round	non-synonymous mutation burden: 241	cohort: Unpaired	NPC0001PT00300T00300	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460332	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070272	10	20	III	Unpaired	Last follow-up	I	undifferentiated, round	241	26.8
Patient 344	GSM2735220	expression-based subtype: II	time to event: 25.06666667	event: Last follow-up	clinical stage: Unknown	% stromal tils: 70	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 14	cohort: Paired	NPC0001PT00344T00344	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460331	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070273	5	70	Unknown	Paired	Last follow-up	II	undifferentiated, round	14	25.06666667
Patient 263	GSM2735221	expression-based subtype: I	time to event: 36.43333333	event: Last follow-up	clinical stage: III	% stromal tils: 30	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 278	cohort: Unpaired	NPC0001PT00263T00263	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460330	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070274	10	30	III	Unpaired	Last follow-up	I	mixed (round & spindle)	278	36.43333333
Patient 75	GSM2735222	expression-based subtype: I	time to event: 29.06666667	event: Last follow-up	clinical stage: III	% stromal tils: 5	% intratumoral tils: 50	morphology: mixed (round & spindle)	non-synonymous mutation burden: 56	cohort: Paired	NPC0001PT00075T00075	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460329	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070275	50	5	III	Paired	Last follow-up	I	mixed (round & spindle)	56	29.06666667
Patient 177	GSM2735223	expression-based subtype: I	time to event: 8.41	event: Disease progression	clinical stage: III	% stromal tils: 20	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 285	cohort: Unpaired	NPC0001PT00177T00177	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460328	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070276	5	20	III	Unpaired	Disease progression	I	mixed (round & spindle)	285	8.41
Patient 12	GSM2735224	expression-based subtype: I	time to event: 36	event: Last follow-up	clinical stage: Unknown	% stromal tils: 90	% intratumoral tils: 10	morphology: differentiated	non-synonymous mutation burden: 17	cohort: Paired	NPC0001PT00012T00012	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460327	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070277	10	90	Unknown	Paired	Last follow-up	I	differentiated	17	36
Patient 16	GSM2735225	expression-based subtype: II	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 60	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: Not evaluated	cohort: N/A	NPC0002PT00016T00016	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460417	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070278	5	60	Unknown	N/A	N/A	II	mixed (round & spindle)	Not evaluated	N/A
Patient 450	GSM2735226	expression-based subtype: III	time to event: 9.266666667	event: Last follow-up	clinical stage: III	% stromal tils: 90	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 91	cohort: Paired	NPC0001PT00450T00450	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460421	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070279	5	90	III	Paired	Last follow-up	III	undifferentiated, round	91	9.266666667
Patient 44	GSM2735227	expression-based subtype: III	time to event: 42.4	event: Last follow-up	clinical stage: III	% stromal tils: 70	% intratumoral tils: 15	morphology: undifferentiated, spindle	non-synonymous mutation burden: Not evaluated	cohort: N/A	NPC0001PT00044T00044	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460420	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070280	15	70	III	N/A	Last follow-up	III	undifferentiated, spindle	Not evaluated	42.4
Patient 438	GSM2735228	expression-based subtype: I	time to event: 14.63333333	event: Last follow-up	clinical stage: III	% stromal tils: 90	% intratumoral tils: 5	morphology: N/A	non-synonymous mutation burden: 17	cohort: Paired	NPC0001PT00438T00438	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460419	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070281	5	90	III	Paired	Last follow-up	I	N/A	17	14.63333333
Patient 422	GSM2735229	expression-based subtype: I	time to event: 28.76666667	event: Last follow-up	clinical stage: III	% stromal tils: 80	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 19	cohort: Paired	NPC0001PT00422T00422	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460418	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070282	10	80	III	Paired	Last follow-up	I	mixed (round & spindle)	19	28.76666667
Patient 354	GSM2735230	expression-based subtype: I	time to event: 17.5	event: Last follow-up	clinical stage: Unknown	% stromal tils: 90	% intratumoral tils: 20	morphology: undifferentiated, round	non-synonymous mutation burden: 1013	cohort: Unpaired	NPC0001PT00354T00354	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460423	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070283	20	90	Unknown	Unpaired	Last follow-up	I	undifferentiated, round	1013	17.5
Patient 96	GSM2735231	expression-based subtype: III	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 40	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 41	cohort: Paired	NPC0001PT00096T00096	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460422	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070284	10	40	Unknown	Paired	N/A	III	mixed (round & spindle)	41	N/A
Patient 19	GSM2735232	expression-based subtype: III	time to event: 33.66666667	event: Last follow-up	clinical stage: IV	% stromal tils: 90	% intratumoral tils: 50	morphology: undifferentiated, round	non-synonymous mutation burden: 146	cohort: Paired	NPC0002PT00019T00019	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460416	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070285	50	90	IV	Paired	Last follow-up	III	undifferentiated, round	146	33.66666667
Patient 452	GSM2735233	expression-based subtype: I	time to event: 12.9	event: Last follow-up	clinical stage: IV	% stromal tils: 50	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 10	cohort: Paired	NPC0001PT00452T00452	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460415	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070286	5	50	IV	Paired	Last follow-up	I	mixed (round & spindle)	10	12.9
Patient 414	GSM2735234	expression-based subtype: II	time to event: 12.43333333	event: Last follow-up	clinical stage: Unknown	% stromal tils: 90	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 238	cohort: Unpaired	NPC0001PT00414T00414	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460414	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070287	10	90	Unknown	Unpaired	Last follow-up	II	mixed (round & spindle)	238	12.43333333
Patient 46	GSM2735235	expression-based subtype: II	time to event: 37.1	event: Last follow-up	clinical stage: III	% stromal tils: 5	% intratumoral tils: 1	morphology: mixed (round & spindle)	non-synonymous mutation burden: Not evaluated	cohort: N/A	NPC0001PT00046T00046	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460413	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070288	1	5	III	N/A	Last follow-up	II	mixed (round & spindle)	Not evaluated	37.1
Patient 99	GSM2735236	expression-based subtype: II	time to event: 39.36666667	event: Last follow-up	clinical stage: III	% stromal tils: 20	% intratumoral tils: 20	morphology: undifferentiated, round	non-synonymous mutation burden: 37	cohort: Paired	NPC0001PT00099T00099	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460412	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070289	20	20	III	Paired	Last follow-up	II	undifferentiated, round	37	39.36666667
Patient 36	GSM2735237	expression-based subtype: II	time to event: 22.76666667	event: Last follow-up	clinical stage: IV	% stromal tils: 30	% intratumoral tils: 15	morphology: mixed (round & spindle)	non-synonymous mutation burden: 19	cohort: Paired	NPC0002PT00036T00036	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460411	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070290	15	30	IV	Paired	Last follow-up	II	mixed (round & spindle)	19	22.76666667
Patient 204	GSM2735238	expression-based subtype: I	time to event: 11.3	event: Disease progression	clinical stage: IV	% stromal tils: 20	% intratumoral tils: 1	morphology: undifferentiated, round	non-synonymous mutation burden: 265	cohort: Unpaired	NPC0001PT00204T00204	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460410	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070291	1	20	IV	Unpaired	Disease progression	I	undifferentiated, round	265	11.3
Patient 13	GSM2735239	expression-based subtype: II	time to event: 14.29	event: Disease progression	clinical stage: IV	% stromal tils: Not evaluated	% intratumoral tils: Not evaluated	morphology: N/A	non-synonymous mutation burden: 257	cohort: Unpaired	NPC0002PT00013T00013	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460409	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070292	Not evaluated	Not evaluated	IV	Unpaired	Disease progression	II	N/A	257	14.29
Patient 286	GSM2735240	expression-based subtype: II	time to event: 20.13333333	event: Last follow-up	clinical stage: III	% stromal tils: 30	% intratumoral tils: 30	morphology: mixed (round & spindle)	non-synonymous mutation burden: 2	cohort: Paired	NPC0001PT00286T00286	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460408	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070293	30	30	III	Paired	Last follow-up	II	mixed (round & spindle)	2	20.13333333
Patient 70	GSM2735241	expression-based subtype: I	time to event: 33.33333333	event: Last follow-up	clinical stage: Unknown	% stromal tils: 60	% intratumoral tils: 10	morphology: differentiated	non-synonymous mutation burden: 13	cohort: Paired	NPC0001PT00070T00070	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460407	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070294	10	60	Unknown	Paired	Last follow-up	I	differentiated	13	33.33333333
Patient 209	GSM2735242	expression-based subtype: I	time to event: 51.33333333	event: Last follow-up	clinical stage: III	% stromal tils: 10	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 248	cohort: Unpaired	NPC0001PT00209T00209	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460406	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070295	5	10	III	Unpaired	Last follow-up	I	mixed (round & spindle)	248	51.33333333
Patient 396	GSM2735243	expression-based subtype: I	time to event: 15.34	event: Disease progression	clinical stage: Unknown	% stromal tils: 5	% intratumoral tils: 10	morphology: undifferentiated, round	non-synonymous mutation burden: 21	cohort: Paired	NPC0001PT00396T00396	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460405	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070296	10	5	Unknown	Paired	Disease progression	I	undifferentiated, round	21	15.34
Patient 294	GSM2735244	expression-based subtype: I	time to event: 32.16666667	event: Last follow-up	clinical stage: III	% stromal tils: 50	% intratumoral tils: 30	morphology: mixed (round & spindle)	non-synonymous mutation burden: 13	cohort: Paired	NPC0001PT00294T00294	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460404	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070297	30	50	III	Paired	Last follow-up	I	mixed (round & spindle)	13	32.16666667
Patient 34	GSM2735245	expression-based subtype: III	time to event: 21.26666667	event: Last follow-up	clinical stage: III	% stromal tils: 90	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 15	cohort: Paired	NPC0002PT00034T00034	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460403	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070298	10	90	III	Paired	Last follow-up	III	mixed (round & spindle)	15	21.26666667
Patient 79	GSM2735246	expression-based subtype: I	time to event: 8.51	event: Disease progression	clinical stage: III	% stromal tils: 30	% intratumoral tils: 10	morphology: undifferentiated, spindle	non-synonymous mutation burden: 18	cohort: Paired	NPC0001PT00079T00079	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460402	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070299	10	30	III	Paired	Disease progression	I	undifferentiated, spindle	18	8.51
Patient 38	GSM2735247	expression-based subtype: III	time to event: 27.26666667	event: Last follow-up	clinical stage: II	% stromal tils: Not evaluated	% intratumoral tils: Not evaluated	morphology: N/A	non-synonymous mutation burden: 239	cohort: Unpaired	NPC0002PT00038T00038	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460401	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070300	Not evaluated	Not evaluated	II	Unpaired	Last follow-up	III	N/A	239	27.26666667
Patient 302	GSM2735248	expression-based subtype: II	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 20	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 68	cohort: Paired	NPC0001PT00302T00302	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460400	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070301	5	20	Unknown	Paired	N/A	II	undifferentiated, round	68	N/A
Patient 240	GSM2735249	expression-based subtype: I	time to event: 36.6	event: Last follow-up	clinical stage: Unknown	% stromal tils: 80	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 255	cohort: Unpaired	NPC0001PT00240T00240	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460399	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070302	10	80	Unknown	Unpaired	Last follow-up	I	mixed (round & spindle)	255	36.6
Patient 233	GSM2735250	expression-based subtype: III	time to event: 16	event: Last follow-up	clinical stage: Unknown	% stromal tils: 95	% intratumoral tils: 5	morphology: undifferentiated, spindle	non-synonymous mutation burden: 17	cohort: Paired	NPC0001PT00233T00233	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460398	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070303	5	95	Unknown	Paired	Last follow-up	III	undifferentiated, spindle	17	16
Patient 55	GSM2735251	expression-based subtype: I	time to event: 32.46	event: Disease progression	clinical stage: IV	% stromal tils: 70	% intratumoral tils: 5	morphology: undifferentiated, spindle	non-synonymous mutation burden: 52	cohort: Paired	NPC0001PT00055T00055	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460397	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070304	5	70	IV	Paired	Disease progression	I	undifferentiated, spindle	52	32.46
Patient 37	GSM2735252	expression-based subtype: I	time to event: 18.4	event: Last follow-up	clinical stage: III	% stromal tils: 90	% intratumoral tils: 2	morphology: differentiated	non-synonymous mutation burden: 275	cohort: Unpaired	NPC0002PT00037T00037	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460396	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070305	2	90	III	Unpaired	Last follow-up	I	differentiated	275	18.4
Patient 445	GSM2735253	expression-based subtype: I	time to event: 12.86666667	event: Last follow-up	clinical stage: IV	% stromal tils: 30	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 41	cohort: Paired	NPC0001PT00445T00445	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460395	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070306	10	30	IV	Paired	Last follow-up	I	mixed (round & spindle)	41	12.86666667
Patient 65	GSM2735254	expression-based subtype: III	time to event: 30.96666667	event: Last follow-up	clinical stage: IV	% stromal tils: 10	% intratumoral tils: 40	morphology: undifferentiated, round	non-synonymous mutation burden: 20	cohort: Paired	NPC0001PT00065T00065	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460394	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070307	40	10	IV	Paired	Last follow-up	III	undifferentiated, round	20	30.96666667
Patient 226	GSM2735255	expression-based subtype: I	time to event: 29.26666667	event: Last follow-up	clinical stage: III	% stromal tils: 40	% intratumoral tils: 30	morphology: mixed (round & spindle)	non-synonymous mutation burden: 277	cohort: Unpaired	NPC0001PT00226T00226	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460393	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070308	30	40	III	Unpaired	Last follow-up	I	mixed (round & spindle)	277	29.26666667
Patient 192	GSM2735256	expression-based subtype: III	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 40	% intratumoral tils: 10	morphology: undifferentiated, round	non-synonymous mutation burden: 293	cohort: Unpaired	NPC0001PT00192T00192	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460392	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070309	10	40	Unknown	Unpaired	N/A	III	undifferentiated, round	293	N/A
Patient 278	GSM2735257	expression-based subtype: II	time to event: 37.13333333	event: Last follow-up	clinical stage: IV	% stromal tils: 90	% intratumoral tils: 20	morphology: N/A	non-synonymous mutation burden: 260	cohort: Unpaired	NPC0001PT00278T00278	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460391	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070310	20	90	IV	Unpaired	Last follow-up	II	N/A	260	37.13333333
Patient 20	GSM2735258	expression-based subtype: I	time to event: 39.5	event: Last follow-up	clinical stage: III	% stromal tils: 90	% intratumoral tils: 20	morphology: undifferentiated, spindle	non-synonymous mutation burden: 36	cohort: Paired	NPC0001PT00020T00020	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460390	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070311	20	90	III	Paired	Last follow-up	I	undifferentiated, spindle	36	39.5
Patient 235	GSM2735259	expression-based subtype: II	time to event: 23.06666667	event: Last follow-up	clinical stage: Unknown	% stromal tils: 20	% intratumoral tils: 10	morphology: undifferentiated, round	non-synonymous mutation burden: 181	cohort: Paired	NPC0001PT00235T00235	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460389	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070312	10	20	Unknown	Paired	Last follow-up	II	undifferentiated, round	181	23.06666667
Patient 392	GSM2735260	expression-based subtype: I	time to event: 19.63333333	event: Last follow-up	clinical stage: III	% stromal tils: 80	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 32	cohort: Paired	NPC0001PT00392T00392	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460326	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070313	5	80	III	Paired	Last follow-up	I	mixed (round & spindle)	32	19.63333333
Patient 389	GSM2735261	expression-based subtype: I	time to event: 19.76666667	event: Last follow-up	clinical stage: I	% stromal tils: 80	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 264	cohort: Unpaired	NPC0001PT00389T00389	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460378	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070314	10	80	I	Unpaired	Last follow-up	I	mixed (round & spindle)	264	19.76666667
Patient 243	GSM2735262	expression-based subtype: I	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 90	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 258	cohort: Unpaired	NPC0001PT00243T00243	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460377	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070315	5	90	Unknown	Unpaired	N/A	I	mixed (round & spindle)	258	N/A
Patient 15	GSM2735263	expression-based subtype: I	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: Not evaluated	% intratumoral tils: Not evaluated	morphology: Not evaluated	non-synonymous mutation burden: Not evaluated	cohort: N/A	NPC0002PT00015T00015	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460376	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070316	Not evaluated	Not evaluated	Unknown	N/A	N/A	I	Not evaluated	Not evaluated	N/A
Patient 54	GSM2735264	expression-based subtype: I	time to event: 17.23333333	event: Last follow-up	clinical stage: III	% stromal tils: 35	% intratumoral tils: 5	morphology: undifferentiated, spindle	non-synonymous mutation burden: 16	cohort: Paired	NPC0001PT00054T00054	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460375	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070317	5	35	III	Paired	Last follow-up	I	undifferentiated, spindle	16	17.23333333
Patient 388	GSM2735265	expression-based subtype: III	time to event: 12.1	event: Last follow-up	clinical stage: III	% stromal tils: 95	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 14	cohort: Paired	NPC0001PT00388T00388	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460374	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070318	5	95	III	Paired	Last follow-up	III	undifferentiated, round	14	12.1
Patient 258	GSM2735266	expression-based subtype: I	time to event: 35.66666667	event: Last follow-up	clinical stage: III	% stromal tils: 50	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 255	cohort: Unpaired	NPC0001PT00258T00258	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460373	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070319	5	50	III	Unpaired	Last follow-up	I	mixed (round & spindle)	255	35.66666667
Patient 332	GSM2735267	expression-based subtype: III	time to event: 26.6	event: Last follow-up	clinical stage: Unknown	% stromal tils: 20	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 301	cohort: Unpaired	NPC0001PT00332T00332	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460372	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070320	5	20	Unknown	Unpaired	Last follow-up	III	mixed (round & spindle)	301	26.6
Patient 306	GSM2735268	expression-based subtype: I	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 30	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 27	cohort: Paired	NPC0001PT00306T00306	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460371	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070321	5	30	Unknown	Paired	N/A	I	mixed (round & spindle)	27	N/A
Patient 229	GSM2735269	expression-based subtype: I	time to event: N/A	event: N/A	clinical stage: III	% stromal tils: 90	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 285	cohort: Unpaired	NPC0001PT00229T00229	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460370	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070322	5	90	III	Unpaired	N/A	I	undifferentiated, round	285	N/A
Patient 290	GSM2735270	expression-based subtype: I	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 95	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 252	cohort: Unpaired	NPC0001PT00290T00290	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460369	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070323	5	95	Unknown	Unpaired	N/A	I	mixed (round & spindle)	252	N/A
Patient 329	GSM2735271	expression-based subtype: II	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 20	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 261	cohort: Unpaired	NPC0001PT00329T00329	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460368	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070324	10	20	Unknown	Unpaired	N/A	II	mixed (round & spindle)	261	N/A
Patient 18	GSM2735272	expression-based subtype: II	time to event: 28.56666667	event: Last follow-up	clinical stage: I	% stromal tils: 80	% intratumoral tils: 5	morphology: N/A	non-synonymous mutation burden: 265	cohort: Unpaired	NPC0002PT00018T00018	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460367	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070325	5	80	I	Unpaired	Last follow-up	II	N/A	265	28.56666667
Patient 391	GSM2735273	expression-based subtype: I	time to event: 26.76666667	event: Last follow-up	clinical stage: Unknown	% stromal tils: 85	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 98	cohort: Paired	NPC0001PT00391T00391	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460366	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070326	5	85	Unknown	Paired	Last follow-up	I	undifferentiated, round	98	26.76666667
Patient 341	GSM2735274	expression-based subtype: I	time to event: 14.23	event: Disease progression	clinical stage: IV	% stromal tils: 40	% intratumoral tils: 5	morphology: differentiated	non-synonymous mutation burden: 23	cohort: Paired	NPC0001PT00341T00341	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460365	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070327	5	40	IV	Paired	Disease progression	I	differentiated	23	14.23
Patient 97	GSM2735275	expression-based subtype: I	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 55	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 40	cohort: Paired	NPC0001PT00097T00097	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460364	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070328	5	55	Unknown	Paired	N/A	I	undifferentiated, round	40	N/A
Patient 5	GSM2735276	expression-based subtype: II	time to event: 55.23333333	event: Last follow-up	clinical stage: III	% stromal tils: Not evaluated	% intratumoral tils: Not evaluated	morphology: N/A	non-synonymous mutation burden: 312	cohort: Unpaired	NPC0001PT00005T00005	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460363	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070329	Not evaluated	Not evaluated	III	Unpaired	Last follow-up	II	N/A	312	55.23333333
Patient 207	GSM2735277	expression-based subtype: III	time to event: 37.73333333	event: Last follow-up	clinical stage: III	% stromal tils: 70	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 271	cohort: Unpaired	NPC0001PT00207T00207	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460362	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070330	5	70	III	Unpaired	Last follow-up	III	undifferentiated, round	271	37.73333333
Patient 355	GSM2735278	expression-based subtype: I	time to event: 32.83333333	event: Last follow-up	clinical stage: III	% stromal tils: 60	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 296	cohort: Unpaired	NPC0001PT00355T00355	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460361	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070331	10	60	III	Unpaired	Last follow-up	I	mixed (round & spindle)	296	32.83333333
Patient 41	GSM2735279	expression-based subtype: II	time to event: 3.19	event: Disease progression	clinical stage: III	% stromal tils: Not evaluated	% intratumoral tils: Not evaluated	morphology: N/A	non-synonymous mutation burden: 266	cohort: Unpaired	NPC0002PT00041T00041	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460360	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070332	Not evaluated	Not evaluated	III	Unpaired	Disease progression	II	N/A	266	3.19
Patient 406	GSM2735280	expression-based subtype: III	time to event: 30.9	event: Last follow-up	clinical stage: I	% stromal tils: 70	% intratumoral tils: 10	morphology: undifferentiated, round	non-synonymous mutation burden: 17	cohort: Paired	NPC0001PT00406T00406	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460359	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070333	10	70	I	Paired	Last follow-up	III	undifferentiated, round	17	30.9
Patient 383	GSM2735281	expression-based subtype: II	time to event: 7.1	event: Last follow-up	clinical stage: Unknown	% stromal tils: 50	% intratumoral tils: 20	morphology: undifferentiated, round	non-synonymous mutation burden: 244	cohort: Unpaired	NPC0001PT00383T00383	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460358	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070334	20	50	Unknown	Unpaired	Last follow-up	II	undifferentiated, round	244	7.1
Patient 144	GSM2735282	expression-based subtype: II	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 60	% intratumoral tils: 30	morphology: undifferentiated, spindle	non-synonymous mutation burden: 18	cohort: Paired	NPC0001PT00144T00144	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460357	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070335	30	60	Unknown	Paired	N/A	II	undifferentiated, spindle	18	N/A
Patient 338	GSM2735283	expression-based subtype: II	time to event: N/A	event: N/A	clinical stage: IV	% stromal tils: 50	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 227	cohort: Unpaired	NPC0001PT00338T00338	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460356	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070336	5	50	IV	Unpaired	N/A	II	undifferentiated, round	227	N/A
Patient 14	GSM2735284	expression-based subtype: I	time to event: 13.93333333	event: Last follow-up	clinical stage: IV	% stromal tils: 60	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 31	cohort: Paired	NPC0001PT00014T00014	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460355	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070337	10	60	IV	Paired	Last follow-up	I	mixed (round & spindle)	31	13.93333333
Patient 173	GSM2735285	expression-based subtype: I	time to event: 41.8	event: Last follow-up	clinical stage: III	% stromal tils: 30	% intratumoral tils: 10	morphology: mixed (round & spindle)	non-synonymous mutation burden: 266	cohort: Unpaired	NPC0001PT00173T00173	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460354	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070338	10	30	III	Unpaired	Last follow-up	I	mixed (round & spindle)	266	41.8
Patient 322	GSM2735286	expression-based subtype: II	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 5	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 246	cohort: Unpaired	NPC0001PT00322T00322	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460353	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070339	5	5	Unknown	Unpaired	N/A	II	mixed (round & spindle)	246	N/A
Patient 407	GSM2735287	expression-based subtype: II	time to event: 26.06666667	event: Last follow-up	clinical stage: I	% stromal tils: 90	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 245	cohort: Unpaired	NPC0001PT00407T00407	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460352	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070340	5	90	I	Unpaired	Last follow-up	II	undifferentiated, round	245	26.06666667
Patient 320	GSM2735288	expression-based subtype: III	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 5	% intratumoral tils: 10	morphology: undifferentiated, spindle	non-synonymous mutation burden: 268	cohort: Unpaired	NPC0001PT00320T00320	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460383	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070341	10	5	Unknown	Unpaired	N/A	III	undifferentiated, spindle	268	N/A
Patient 305	GSM2735289	expression-based subtype: III	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 20	% intratumoral tils: 40	morphology: undifferentiated, round	non-synonymous mutation burden: 292	cohort: Unpaired	NPC0001PT00305T00305	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460382	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070342	40	20	Unknown	Unpaired	N/A	III	undifferentiated, round	292	N/A
Patient 71	GSM2735290	expression-based subtype: I	time to event: 5	event: Last follow-up	clinical stage: III	% stromal tils: 10	% intratumoral tils: 20	morphology: mixed (round & spindle)	non-synonymous mutation burden: 15	cohort: Paired	NPC0001PT00071T00071	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460351	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070343	20	10	III	Paired	Last follow-up	I	mixed (round & spindle)	15	5
Patient 439	GSM2735291	expression-based subtype: II	time to event: 13.4	event: Last follow-up	clinical stage: Unknown	% stromal tils: 30	% intratumoral tils: 30	morphology: undifferentiated, round	non-synonymous mutation burden: 22	cohort: Paired	NPC0001PT00439T00439	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460350	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070344	30	30	Unknown	Paired	Last follow-up	II	undifferentiated, round	22	13.4
Patient 237	GSM2735292	expression-based subtype: I	time to event: 36.9	event: Last follow-up	clinical stage: Unknown	% stromal tils: 70	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 257	cohort: Unpaired	NPC0001PT00237T00237	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460388	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070345	5	70	Unknown	Unpaired	Last follow-up	I	undifferentiated, round	257	36.9
Patient 293	GSM2735293	expression-based subtype: I	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 20	% intratumoral tils: 5	morphology: undifferentiated, spindle	non-synonymous mutation burden: 258	cohort: Unpaired	NPC0001PT00293T00293	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460387	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070346	5	20	Unknown	Unpaired	N/A	I	undifferentiated, spindle	258	N/A
Patient 151	GSM2735294	expression-based subtype: II	time to event: 15.28	event: Disease progression	clinical stage: Unknown	% stromal tils: 10	% intratumoral tils: 40	morphology: undifferentiated, round	non-synonymous mutation burden: 18	cohort: Paired	NPC0001PT00151T00151	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460386	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070347	40	10	Unknown	Paired	Disease progression	II	undifferentiated, round	18	15.28
Patient 260	GSM2735295	expression-based subtype: I	time to event: 14.29	event: Disease progression	clinical stage: IV	% stromal tils: 20	% intratumoral tils: 15	morphology: mixed (round & spindle)	non-synonymous mutation burden: 39	cohort: Paired	NPC0001PT00260T00260	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460385	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070348	15	20	IV	Paired	Disease progression	I	mixed (round & spindle)	39	14.29
Patient 69	GSM2735296	expression-based subtype: I	time to event: 25.82	event: Disease progression	clinical stage: IV	% stromal tils: 90	% intratumoral tils: 20	morphology: differentiated	non-synonymous mutation burden: 20	cohort: Paired	NPC0001PT00069T00069	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460384	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070349	20	90	IV	Paired	Disease progression	I	differentiated	20	25.82
Patient 40	GSM2735297	expression-based subtype: II	time to event: 22.9	event: Last follow-up	clinical stage: IV	% stromal tils: Not evaluated	% intratumoral tils: Not evaluated	morphology: N/A	non-synonymous mutation burden: 256	cohort: Unpaired	NPC0002PT00040T00040	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460381	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070350	Not evaluated	Not evaluated	IV	Unpaired	Last follow-up	II	N/A	256	22.9
Patient 443	GSM2735298	expression-based subtype: II	time to event: 21.53333333	event: Last follow-up	clinical stage: III	% stromal tils: 0	% intratumoral tils: 40	morphology: undifferentiated, round	non-synonymous mutation burden: 270	cohort: Unpaired	NPC0001PT00443T00443	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460380	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070351	40	0	III	Unpaired	Last follow-up	II	undifferentiated, round	270	21.53333333
Patient 298	GSM2735299	expression-based subtype: II	time to event: 29.76666667	event: Last follow-up	clinical stage: III	% stromal tils: 40	% intratumoral tils: 20	morphology: undifferentiated, round	non-synonymous mutation burden: 70	cohort: Paired	NPC0001PT00298T00298	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460379	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070352	20	40	III	Paired	Last follow-up	II	undifferentiated, round	70	29.76666667
Patient 56	GSM2735300	expression-based subtype: I	time to event: 13.83	event: Disease progression	clinical stage: IV	% stromal tils: 30	% intratumoral tils: 10	morphology: undifferentiated, round	non-synonymous mutation burden: 14	cohort: Paired	NPC0001PT00056T00056	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460438	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070353	10	30	IV	Paired	Disease progression	I	undifferentiated, round	14	13.83
Patient 337	GSM2735301	expression-based subtype: I	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 40	% intratumoral tils: 20	morphology: N/A	non-synonymous mutation burden: 25	cohort: Paired	NPC0001PT00337T00337	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460437	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070354	20	40	Unknown	Paired	N/A	I	N/A	25	N/A
Patient 421	GSM2735302	expression-based subtype: III	time to event: N/A	event: N/A	clinical stage: IV	% stromal tils: 10	% intratumoral tils: 5	morphology: undifferentiated, spindle	non-synonymous mutation burden: Not evaluated	cohort: N/A	NPC0001PT00421T00421	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460436	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070355	5	10	IV	N/A	N/A	III	undifferentiated, spindle	Not evaluated	N/A
Patient 426	GSM2735303	expression-based subtype: I	time to event: 26.8	event: Last follow-up	clinical stage: IV	% stromal tils: 90	% intratumoral tils: 20	morphology: mixed (round & spindle)	non-synonymous mutation burden: 257	cohort: Unpaired	NPC0001PT00426T00426	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460435	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070356	20	90	IV	Unpaired	Last follow-up	I	mixed (round & spindle)	257	26.8
Patient 296	GSM2735304	expression-based subtype: II	time to event: 20.73333333	event: Last follow-up	clinical stage: III	% stromal tils: 55	% intratumoral tils: 5	morphology: undifferentiated, spindle	non-synonymous mutation burden: 313	cohort: Unpaired	NPC0001PT00296T00296	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460434	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070357	5	55	III	Unpaired	Last follow-up	II	undifferentiated, spindle	313	20.73333333
Patient 346	GSM2735305	expression-based subtype: I	time to event: 17.56666667	event: Last follow-up	clinical stage: IV	% stromal tils: 90	% intratumoral tils: 1	morphology: differentiated	non-synonymous mutation burden: 266	cohort: Unpaired	NPC0001PT00346T00346	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460433	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070358	1	90	IV	Unpaired	Last follow-up	I	differentiated	266	17.56666667
Patient 178	GSM2735306	expression-based subtype: I	time to event: N/A	event: N/A	clinical stage: IV	% stromal tils: 10	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 268	cohort: Unpaired	NPC0001PT00178T00178	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460432	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070359	5	10	IV	Unpaired	N/A	I	undifferentiated, round	268	N/A
Patient 27	GSM2735307	expression-based subtype: I	time to event: 16.76666667	event: Last follow-up	clinical stage: IV	% stromal tils: 50	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: Not evaluated	cohort: N/A	NPC0001PT00027T00027	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460431	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070360	5	50	IV	N/A	Last follow-up	I	undifferentiated, round	Not evaluated	16.76666667
Patient 336	GSM2735308	expression-based subtype: III	time to event: 19.33333333	event: Last follow-up	clinical stage: III	% stromal tils: 70	% intratumoral tils: 5	morphology: undifferentiated, round	non-synonymous mutation burden: 7	cohort: Paired	NPC0001PT00336T00336	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460430	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070361	5	70	III	Paired	Last follow-up	III	undifferentiated, round	7	19.33333333
Patient 1	GSM2735309	expression-based subtype: II	time to event: N/A	event: N/A	clinical stage: III	% stromal tils: Not evaluated	% intratumoral tils: Not evaluated	morphology: N/A	non-synonymous mutation burden: Not evaluated	cohort: N/A	NPC0001PT00001T00001	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460429	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070362	Not evaluated	Not evaluated	III	N/A	N/A	II	N/A	Not evaluated	N/A
Patient 357	GSM2735310	expression-based subtype: I	time to event: 24.93333333	event: Last follow-up	clinical stage: III	% stromal tils: 20	% intratumoral tils: 40	morphology: undifferentiated, round	non-synonymous mutation burden: 251	cohort: Unpaired	NPC0001PT00357T00357	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460428	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070363	40	20	III	Unpaired	Last follow-up	I	undifferentiated, round	251	24.93333333
Patient 369	GSM2735311	expression-based subtype: I	time to event: 28	event: Last follow-up	clinical stage: III	% stromal tils: 10	% intratumoral tils: 1	morphology: mixed (round & spindle)	non-synonymous mutation burden: 24	cohort: Paired	NPC0001PT00369T00369	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460427	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070364	1	10	III	Paired	Last follow-up	I	mixed (round & spindle)	24	28
Patient 431	GSM2735312	expression-based subtype: III	time to event: N/A	event: N/A	clinical stage: Unknown	% stromal tils: 10	% intratumoral tils: 20	morphology: undifferentiated, spindle	non-synonymous mutation burden: 15	cohort: Paired	NPC0001PT00431T00431	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460426	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070365	20	10	Unknown	Paired	N/A	III	undifferentiated, spindle	15	N/A
Patient 39	GSM2735313	expression-based subtype: II	time to event: 12.3	event: Last follow-up	clinical stage: I	% stromal tils: Not evaluated	% intratumoral tils: Not evaluated	morphology: N/A	non-synonymous mutation burden: 262	cohort: Unpaired	NPC0002PT00039T00039	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460425	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070366	Not evaluated	Not evaluated	I	Unpaired	Last follow-up	II	N/A	262	12.3
Patient 221	GSM2735314	expression-based subtype: I	time to event: 7.49	event: Disease progression	clinical stage: III	% stromal tils: 30	% intratumoral tils: 5	morphology: mixed (round & spindle)	non-synonymous mutation burden: 248	cohort: Unpaired	NPC0001PT00221T00221	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN07460424	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX3070367	5	30	III	Unpaired	Disease progression	I	mixed (round & spindle)	248	7.49
